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A Novel SCN1A Mutation Associated with Generalized Epilepsy with
Febrile Seizures Plus—and Prevalence of Variants in Patients with Epilepsy
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We recently described mutations of the neuronal sodium-channel a-subunit gene, SCN1A, on chromosome 2q24
in two families with generalized epilepsy with febrile seizures plus (GEFS+) type 2. To assess the contribution that
SCN1A makes to other types of epilepsy, 226 patients with either juvenile myoclonic epilepsy, absence epilepsy, or
febrile convulsions were screened by conformation-sensitive gel electrophoresis and manual sequencing of variants;
the sample included 165 probands from multiplex families and 61 sporadic cases. The novel mutation W1204R
was identified in a family with GEFS+. Seven other coding changes were observed; three of these are potential
disease-causing mutations. Two common haplotypes, with frequencies of .67 and .33, were defined by five single-
nucleotide polymorphisms (SNPs) spanning a 14-kb region of linkage disequilibrium. An SNP located 18 bp
upstream of the splice-acceptor site for exon 3 was observed in 7 of the 226 patients but was not present in 185
controls, suggesting possible association with a disease mutation. This work has confirmed the role of SCN1A in
GEFS+, by identification of a novel mutation in a previously undescribed family. Although a few candidate disease
alleles were identified, the patient survey suggests that SCN1A is not a major contributor to idiopathic generalized
epilepsy. The SCN1A haplotypes and SNPs identified here will be useful in future association and linkage studies.
Introduction
Recent progress in the positional cloning of genes re-
sponsible for monogenic epilepsies has demonstrated the
involvement of ion-channel genes in several rare disor-
ders (McNamara 1999). Sodium-channel mutations
have been demonstrated for the epilepsy syndrome
GEFS (generalized epilepsy with febrile seizures plus)
(MIM 604236 and MIM 604233). Individuals with
GEFS are characterized by febrile seizures that persist
beyond age 6 years and by heterogeneous afebrile sei-
zures that may include tonic-clonic, myoclonic, atonic,
and absence seizures (Scheffer and Berkovic 1997). A
mutation in the voltage-gated sodium-channel b-sub-
unit SCN1B was identified in 1998 in a family with
GEFS type 1 linked to chromosome 19p13 (Wallace
et al. 1998). We described mutations of the neuronal
sodium-channel a-subunit SCN1A in two families with
GEFS type 2 linked to chromosome 2q24 (Escayg et
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al. 2000b). In the mouse, mutation of the related so-
dium-channel SCN2A also results in a dominantly in-
herited, progressive seizure disorder (Kearney et al.
2001).
SCN1A is one of the four voltage-gated sodium chan-
nels that are widely expressed in neurons of the CNS
and peripheral nervous system (PNS) (Plummer and
Meisler 1999). The differences in firing patterns and
excitability of different classes of neurons are influenced
by their specific complement of voltage-gated sodium,
potassium, and calcium channels, as well as by the ex-
tent of posttranslational modifications of the channel
proteins. Subtle differences in channel properties can
have significant physiological effects and may underlie
individual variation in neurological function (Kohrman
et al. 1996; Bulman 1997).
The observation that patients with GEFS experience
several types of seizures has suggested that genetic var-
iation in SCN1A could contribute to other common
forms of idiopathic generalized epilepsy. To test this pos-
sibility, we screened 226 patients with either juvenile my-
oclonic epilepsy (JME), childhood or juvenile absence
epilepsy (CAE and JAE, respectively), febrile convulsions
(FC), or generalized tonic-clonic seizures (GTCS).Twenty
SCN1A variants were identified, including 8 amino acid
substitutions and 12 noncoding variants. One amino acid
substitution, W1204R, cosegregated with GEFS in a
previously undescribed family, making this the third
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Figure 1 Mutation W1204R, cosegregating with disease in a family with GEFS. A, Family with GEFS, with 13 individuals from four
generations. Six individuals were classified as affected. DNA was obtained from five affected and three unaffected family members. CSGE
analysis of exon 18 of SCN1A identified a unique pattern in the proband (arrow). The same pattern was observed in the other affected
individuals. B, Sequence analysis revealing a TrC transition (arrow) resulting in amino acid substitution W1204R.
SCN1A mutation associated with GEFS. Several vari-
ants identified in sporadic cases require further testing as
possible susceptibility factors.
Subjects and Methods
Subjects
DNA was obtained from index patients from 165 un-
related families with idiopathic generalized epilepsy
(Haug et al. 2000; Sander et al. 2000). These patients
included 72 with JME, 83 patients with either CAE or
JAE, 4 with random GTCS on awakening, and 6 with
a history of FC, who had at least one first-degree rela-
tive who was affected. Sixty-one sporadic cases of idi-
opathic generalized epilepsy (IGE) were also included in
the study. Diagnostic classification followed the proposal
of the Commission on Classification and Terminology
of the International League Against Epilepsy (1989). The
diagnosis of JME was based on repetitive myoclonic
jerks, in arms and shoulders, on awakening. Diagnostic
criteria for idiopathic absence epilepsy were a brief loss
of consciousness with pyknoleptic daily clusters of ab-
sence seizures. The diagnosis for FC followed the pro-
posal of the National Institutes of Health Consensus
Development Panel (Consensus Statement 1980). Elec-
troencephalography (EEG) recordings were obtained
from most patients and demonstrated a normal back-
ground activity. Paroxysmal generalized spike-and-wave
discharges were present in the patients with IGE. Each
SCN1A variant observed in patients was assayed in
96–268 ethnically matched, unrelated controls who had
been described elsewhere (Haug et al. 2000; Sander et
al. 2000). Written consent was obtained from all par-
ticipants, and the study was approved by the institu-
tional ethics committees.
Mutation Detection
The 26 exons of SCN1A were individually amplified
from genomic DNA in 28 PCR reactions using primers
based on intronic sequence (Escayg et al. 2000b). PCR
amplification was performed at 32 cycles of 1 min at
94C, 45 s at 60C, and 1 min at 72C. PCR products
were incubated at 99C for 10 min, followed by 35 min
at 68C to facilitate heteroduplex formation, and were
analyzed by conformation-sensitive gel electrophoresis
(CSGE) with visualization by ethidium bromide staining
as described elsewhere (Escayg et al. 2000a). PCR prod-
ucts with mobility variants were gel purified by means
of the Qiaex II gel extraction kit (Qiagen) and were
manually sequenced by means of the ThermoSequenase
sequencing kit (USB).
Statistical Analysis
Allele and genotype frequencies in the patients and in
the control groups were compared by either x2 analysis
or Fisher’s exact test. A two-tailed type I error rate of
5% was chosen for the analyses. A correction for mul-
tiple testing was performed according to the Bonferroni
procedure.
Results
W1204R: Cosegregation with GEFS
Multiple members of a previously undescribed family
from Germany had a history of febrile and afebrile sei-
zures consistent with the classification of GEFS (Schef-
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Table 1
Clinical Features of Affected Individuals from the Family with GEFS+
AFFECTED
INDIVIDUAL
AGE
(years)
TYPE OF
AFEBRILE SEIZURE
CLINICAL RESULTS
At Onset of FC At Last FC EEG MRI
II-2 None … Unknown Not available Not available
II-3 .5 5 None Not available Not available
III-1 1 8 GTCS Normal Not available
IV-1 2 7 Myoclonic-astatic Sharp slow waves, spike waves, polyspike wave Normal
IV-3 None … Myoclonic Polyspike wave Normal
IV-4 1 6 GTCS Irregular spike waves Normal
NOTE.—The family pedigree is shown in figure 1.
Figure 2 Amino acid substitutions in SCN1A that are identified in the present study. The sodium channel is composed of four internally
homologous domains, D1–D4, each containing six transmembrane segments. The eight amino acid substitutions identified in the patient population
are located in cytoplasmic loops 1 and 2. The only change that affects an evolutionarily conserved residue is W1204, located close to the cytoplasmic
surface of transmembrane domain D3. Exon/intron boundaries are marked by horizontal bars; exon designations are in italics.
fer and Berkovic 1997). The four-generation pedigree is
presented in figure 1. Six individuals in this family were
classified as affected (table 1). Individuals III-1, IV-1, and
IV-4 reported a history of childhood febrile and afebrile
seizures. Individual II-3 had febrile seizures until age 5
years but did not have afebrile seizures. The proband
(IV-3) was diagnosed with severe myoclonic seizures and
did not have a history of febrile seizures. A detailed
family history indicated that individual II-2 had epilepsy
as an adult. The disease status of individual I-2 is unclear.
EEG recordings and results of magnetic-resonance im-
aging (MRI) were obtained for selected individuals (table
1). Normal EEG patterns were recorded from the un-
affected individuals: III-2, IV-2, and IV-5. Results of neu-
rological examination were normal in all individuals ex-
cept IV-1, who had mild intellectual disability and severe
seizures that resulted in permanent institutional care.
The clinical features of the affected members of this fam-
ily are summarized in table 1.
DNA samples from the eight living family members
were screened for SCN1A mutations. The abnormal
CSGE conformer of exon 18 was observed in the pro-
band and in the other four affected individuals (fig. 1A).
Sequence analysis of the PCR product revealed a TrC
transition that was responsible for the amino acid sub-
stitution W1204R (fig. 1B). The three unaffected family
members did not carry the mutation. This nonconser-
vative amino acid substitution was not observed in 268
unaffected controls (536 chromosomes). W1204 is lo-
cated in cytoplasmic loop 2, within 10 amino acids of
the transmembrane segment D3S1 (fig. 2). The func-
tional importance of this residue is demonstrated by ev-
olutionary conservation in 12 of 13 mammalian, ver-
tebrate, and invertebrate sodium channels (fig. 3).
Mutation Screening
Two hundred twenty-five additional patients were
screened by exon amplification and CSGE. Nineteen ad-
ditional variants were detected, including 18 single-nu-
cleotide polymorphisms (SNPs) and 1 dinucleotide de-
letion (table 2); 7 of these SNPs encoded novel amino
acid substitutions. Allele frequencies for six coding SNPs
(cSNPs) were !1% and did not differ significantly be-
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Figure 3 Evolutionary conservation of tryptophan residue 1204. W1204 is located 10 residues upstream of transmembrane segment D3S1.
This residue is highly conserved in vertebrate and invertebrate channels, including all of the other members of the mammalian gene family. The
SCN1A sequence is that reported by Escayg et al. (2000b); GenBank accession numbers, from top to bottom, are M94055, AJ251507,M81758,
M77235, AB027567.1, X82835, AF117907.1, AF188679, D37977, M22252, M32078, and AF047380. Electric eelp Electrophorus electricus;
Drosophila p D. melanogaster; jellyfish p Polyorchis penicillatus.
tween patient and control populations ( , byP 1 .05
Fisher’s exact test). One coding variant, T1067A, was
polymorphic in patients and controls, with an allele fre-
quency of .33 in both groups.
Three coding variants identified in familial cases did
not cosegregate with the disease. V699I in exon 12 was
identified in the proband of a family with JAE and FC.
Other affected family members did not carry the mu-
tation. R604H in exon 11 was identified in two pro-
bands from unrelated families with JME. The mutant
allele in one of the two families carries the substitution
A1161T, in exon 17, which cosegregates with R604H
(table 2). R604H disrupts a protein kinase A (PKA) con-
sensus site that is conserved in the four major sodium
channels of the CNS (fig. 4A). Analysis of DNA from
additional family members demonstrated multiple re-
combinations with the disease, including affected indi-
viduals in both families who did not carry the mutation
(data not shown).
Three cSNPs were identified in sporadic cases of ep-
ilepsy for which family records were not available.
R542Q was found in a patient with JME and is located
in a consensus tyrosine kinase phosphorylation site (fig.
4B). G1081R and T1174S were identified in patients
with JAE and JME, respectively, and T1174S was also
observed in one control (table 2). Since family members
were not available for analysis, the role that these amino
acid substitutions play in seizure susceptibility could not
be evaluated and warrants further analysis. The rela-
tionship between the eight coding variants and disease
status is summarized in table 3.
Noncoding SNPs
Seven noncoding SNPs were present at polymorphic
frequencies (i.e., 11% ) (table 2), and five were present
at lower frequencies. Allele frequencies did not differ
significantly between the 226 patients and 96–194 eth-
nically matched controls, with one exception: the SNP
in intron 2 appeared to be more frequent in patients (7/
226) than in controls (0/185) ( , by Fisher’s ex-Pp .019
act test [two tailed]), but the difference between the pa-
tients and controls was not significant after correction
for multiple testing. The patients with this variant were
diagnosed as having JAE (4 cases), JME (2 cases), or
CAE (1 case). Additional studies, in independent sam-
ples, will be required in order to determine whether this
SNP is associated with predisposition to epilepsy.
SCN1A Haplotypes
Two major haplotypes are defined by the consistent
association of five SNPs in SCN1A in 322 unrelated
individuals, including patients and controls (table 4).
Haplotypes 1 and 2 exhibit frequencies of .67 and .33
in this northern-European population. The genotype fre-
quencies are in agreement with Hardy-Weinberg expec-
tations. The haplotypes were confirmed by cosegregation
in meiosis (data not shown). Minor haplotypes are de-
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Table 2
Single-Nucleotide Substitutions in Human SCN1A
LOCATION
cDNA NUCLEOTIDEa
(AMINO ACID CHANGE)
MAJOR/MINOR
SNP ALLELES
NO. (FREQUENCY) OF MINOR ALLELE IN
HAPLOTYPE OF
MINOR ALLELEc226 Patients 96 Controlsb
Intron 2 38420 G/C 7 (.02) 0 [185] 2
Intron 6 96521 T/C 151 (.33) 64 (.33) 2
Intron 7 102821 C/T …d … …
Exon 8 1131 A/C 2 (.004) 4 (.02) [194] 1
Intron 8 11719,10 TT/DTT 16 (.04) 7 (.04) 1
Exon 9 1212 G/A 151 (.33) 64 (.33) 2
Exon 10 1625 (R542Q) G/A 1 (.002) 0 1
Exon 11 1811 (R604H) G/A 2 (.004) 0 1
Exon 12 2095 (V699I) G/A 1 (.002) 0 1
Exon 13 2292 C/T 151 (.33) 64 (.33) 2
Intron 13 241637 C/A 151 (.33) 64 (.33) 2
Intron 13 241672 A/G …d … …
Exon 16 3199 (T1067A) A/G 151 (.33) 64 (.33) 2
Exon 16 3241 (G1081R) G/A 1 (.002) 0 …
Exon 17 3481 (A1161T) G/A 1 (.002) 0 1
Exon 17 3521 (T1174S) C/G 1 (.002) 1 (.005) …
Exon 18 3610 (W1204R) T/C 1 (.002) 0 [268] 1
Intron 23 447633 G/A 4 (.009) 2 (.01) 2
Exon 25 4731 T/C 1 (.002) 1 (.005) …
Exon 26 5418 G/A 8 (.02) 3 (.005) [183] 2
a Nucleotide position is that of human SCN1A cDNA (Escayg et al. 2000b).
b In those cases in which 196 controls were tested, the total number is shown in square brackets.
c Haplotypes are as in table 4.
d Identified by sequencing a small number of individuals.
Figure 4 SCN1A variants R604H and R542Q, which disrupt potential sites of protein phosphorylation. A, Consensus protein kinase A
site in exon 11 (underlined), which is conserved in several sodium channels and is disrupted by the substitution R604H. B, Consensus tyrosine
kinase phosphorylation site in exon 10 (underlined), which is present only in SCN1A and is disrupted by the substitution R542Q.
fined by the rare SNPs, which are all restricted to either
haplotype 1 or haplotype 2 (table 2).
The SNPs defining the haplotypes span a 14-kb region
of linkage disequilibrium (LD) in SCN1A (fig. 5). The
positions of related sodium-channel genes in the cluster
on chromosome 2q24 are shown on the clone contig,
which was generated by BLAST alignment of cDNA and
genomic sequences in the GenBank high-throughput ge-
nomic-sequence database. In the cluster, SCN1A and
SCN2A are orientated tail-to-tail, with their C-terminal
coding exons separated by 600 kb. SCN2A and SCN3A
are orientated head-to-head separated by 100 kb that
could contain shared regulatory sequences. The PNS-
channel SCN9A is located 120 kb distal to SCN1A. The
microsatellite D2S2330, located between SCN1A and
SCN2A, is closely linked to the inherited epilepsy locus
FEB3 (Peiffer et al. 1999), indicating that SCN1A and
SCN2A are strong candidates genes for this disorder.
Discussion
This is the first systematic study of population variation
in a neuronal sodium-channel a-subunit gene. We have
identified 20 variants of SCN1A, including 8 amino acid
substitutions, in 226 patients with IGE subtypes and FC.
The amino acid substitution W1204R has been found
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Table 3
Coding Variation in SCN1A, and Relationship to Disease
Substitution Domain Type of Epilepsy Genetic Observation(s)
W1204R Loop 2 GEFS type 2 Cosegregates with disease
R604H Loop 1 Familial JME (two families) Discordant; absent in several affected family members
V699I Loop 1 Familial JAE with FC Discordant; absent in affected parent and affected sib
A1161T Loop 2 Familial JME Discordant; absent in several affected family members
R542Q Loop 1 Sporadic JME Family not available
G1081R Loop 2 Sporadic JAE Family not available
T1174S Loop 2 Sporadic JME Family not available
T1067A Loop 2 All Polymorphic in patients and controls
Table 4
Two Major SCN1A Haplotypes
HAPLOTYPE
(NO. [FREQUENCY])
SNP AT
Intron 6: 965-21 Exon 9: 1212 Exon 13: 2292 Intron 13: 241637 Exon 16: 3199
1 (429 [.67]) T G C C A
2 (215 [.33]) C A T A G
NOTE.—Data are for 322 unrelated individuals. Genotype frequencies were consistent with Hardy-Weinberg
equilibrium.
to cosegregate with GEFS, making this the third
SCN1A mutation associated with this disease (Escayg et
al. 2000b). It is interesting that the proband in this fam-
ily had JME, without any history of febrile seizures or
other seizure types. Four other variants identified in this
study are potentially associated with disease. The dif-
ference, in frequency of the SNP in intron 2, between
patients (7/226) and controls (0/185) approached sig-
nificance, and follow-up studies to detect possible disease
association with this variant are warranted. The three
amino acid substitutions identified in sporadic cases of
epilepsy could also be predisposing mutations and will
require further analysis.
The 226 patients were screened for all 26 exons of
SCN1A, and variants were found in 15 exons (table 2).
The 96 controls were then screened for these 15 exons
only. No novel variants were found in the controls. Rare
coding variants of SCN1A were present in 8/226 pa-
tients and 1/96 controls. As more data accumulate, it
will be interesting to determine whether rare coding
variants of sodium channels are consistently more prev-
alent in patient populations.
All of the coding variants identified in this study are
located in the cytoplasmic loops of the sodium-channel
protein (fig. 2). The voltage-gated sodium channels con-
tain four domains (D1–D4), each with six transmem-
brane segments. The transmembrane segments are among
the most highly conserved protein domains known. The
large cytoplasmic loops are less well conserved among
different members of the sodium-channel family, but they
are well conserved among mammalian orthologues. The
two cytoplasmic loops of human SCN1A exhibit amino
acid sequence identity of 98% (330/337) and 96% (213/
221) with SCN1A from rat or mouse, suggesting func-
tional constraints throughout these domains. In the cy-
toplasmic loops, the only functional motifs that have
been recognized thus far are phosphorylation sites (Smith
and Goldin 1997; Ratcliffe et al. 2000). Phosphorylation
of five protein kinase A sites in loop 1 of SCN2A can
attenuate sodium current amplitude (Smith and Goldin
1997). The PKA site corresponding to R604H had a
minor effect on current amplitude in a previous study
(Smith and Goldin 1997) and did not cosegregate with
the seizure disorder in two families with JME. Sodium
channels may be modulated by tyrosine phosphorylation
(Ratcliffe et al. 2000), and the variant R542Q disrupts
a predicted tyrosine kinase site in exon 10 of SCN1A.
Another possible function of the cytoplasmic loops is
channel clustering and subcellular localization (Sampo et
al. 2000), but specific residues involved in these processes
have not been identified.
The amino acid substitution T1067A was observed
at a frequency of .33 both in patients and in controls
and is clearly a nonpathogenic polymorphism. The sub-
stitutions G1081R and T1174S were observed at very
low frequency in sporadic cases, and T1174S was also
present in one control individual. Understanding the
significance of the coding variants in the cytoplasmic
loops will depend on further elucidation of the functions
of these domains.
The two previously identified SCN1A mutations in
GEFS were located in the voltage-responsive S4 seg-
ments (Escayg et al. 2000b). The GEFS mutation de-
scribed here, W1204R, is located in the second cyto-
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Figure 5 Physical map of sodium-channel gene cluster on chromosome 2q24. Arrows indicate direction of transcription of sodium-channel
genes. The positions of polymorphic microsatellites are indicated. BLAST analysis of the GenBank high-throughput genomic-sequence database
was used to construct the 1.6-Mb contig containing SCN1A, SCN2A, SCN3A, and SCN9A. The GenBank accession number of each bacterial
artificial chromosome is indicated. LD p 14-kb region of LD in SCN1A.
plasmic loop, 10 residues distant from the cytoplasmic
surface of the transmembrane segment D3S1. The ev-
olutionary conservation of W1204 is strong evidence
for an important function for this residue. Many disease
mutations of the muscle and cardiac sodium channels
SCN4A and SCN5A are located in similar sites near the
cytoplasmic surfaces of transmembrane segments (Bul-
man 1997). There are evidently functional constraints
on other residues, between W1204 and the start of
D3S1, since they are highly conserved in the 11 verte-
brate and 2 invertebrate sodium channels compared in
figure 3. The number of channels with identical amino
acids are as follows: W1204, 12/13; W1205, 11/13;
R1208, 13/13;, R/K1209, 13/13; and T1210, 10/13.
Functional analysis of the W1204R mutation in Xen-
opus oocytes and mammalian cells will be important
for understanding its effect on channel activity.
Four GEFS mutations are now known—three in
SCN1A and one in the b-subunit SCN1B. If the SCN1B
mutation is a loss-of-function mutation, as has been
reported elsewhere (Wallace et al. 1998), it would result
in slower inactivation of the associated a-subunit, lead-
ing to increased persistent current and neuronal hyper-
excitability. Persistent sodium currents are thought to
underlie ictal epileptiform activity in the brain, and
SCN1A is expressed in the cell bodies of many neurons
that generate persistent currents. Thus, a common elec-
trophysiological mechanism may underlie epilepsies
caused by mutations in SCN1A and SCN1B. Structure/
function analysis in heterologous expression systems
and in transgenic mice will be required in order to elu-
cidate the precise kinetic and physiological conse-
quences of these mutations.
The present study confirms the role that SCN1A plays
in the etiology of GEFS. The phenotypic variability
in families with GEFS raises the possibility that the
incidence of GEFS has been underestimated, since, in
the absence of a complete family medical history, in-
dividuals with GEFS may be misclassified as mani-
festing one of the more common syndromes of IGE.
SCN1A should also be considered as a candidate for
other inherited epilepsy syndromes associated with FC,
which were not tested in the present study. When func-
tional assays for functional domains in the cytoplasmic
loops of the sodium channels are developed, it will be
of great interest to determine whether the variants de-
scribed here influence channel function. The SNPs and
the physical map of the sodium-channel gene cluster
will be useful for testing the contributions that these
genes make to other inherited disorders. Studies of al-
lelic mutations of SCN8A in the mouse have demon-
strated that mutations of a single sodium channel can
generate a variety of neurological symptoms (e.g.,
ataxia, tremor, a dystonic movement disorder, and pa-
ralysis) (Meisler et al. 1997, and in press). We anticipate
that mutations in the human sodium channels will be
found to contribute to a broad spectrum of inherited
disease.
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